Emergent Biosolutions EBS Deferred Taxes
Deferred Taxes at other companies
Other financials
Where this comes from
Reported directly by Emergent Biosolutions in its filing.
Tagged under the XBRL concept us-gaap:DeferredIncomeTaxLiabilitiesNet.
The official record: Emergent Biosolutions’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Emergent Biosolutions's deferred taxes.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Emergent Biosolutions's deferred taxes?
- Emergent Biosolutions (EBS) reported deferred taxes of $33.3M in Q1 2026.
- How has Emergent Biosolutions's deferred taxes changed year-over-year?
- Emergent Biosolutions's deferred taxes decreased by 44.9% year-over-year, from $60.4M to $33.3M.
- What is the long-term trend for Emergent Biosolutions's deferred taxes?
- Over 5 years (2020 to 2025), Emergent Biosolutions's deferred taxes has grown at a -6.6% compound annual growth rate (CAGR), from $53.2M to $37.8M.
- What does deferred taxes mean?
- This represents the net amount of income taxes that will be payable in future periods due to temporary differences between the carrying amount of assets and liabilities for financial reporting and their tax bases. It reflects the long-term tax impact of accounting choices and depreciation schedules. Investors use this to understand future tax obligations and the impact of tax timing on cash flow.